These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34362151)

  • 1. Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents.
    Yoon GS; Kim SH; Kang SH; Yoon CH; Cho YS; Youn TJ; Chae IH
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study.
    Park J; Choi EK; Han KD; Choi YJ; Lee SR; Cha MJ; Kang J; Park KW; Oh S; Lip GYH
    Am J Cardiol; 2019 Jun; 123(12):1921-1926. PubMed ID: 30967291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease.
    Lee SR; Jung JH; Choi EK; Lee SW; Kwon S; Park JS; Kang J; Han KD; Park KW; Oh S; Lip GYH
    Front Cardiovasc Med; 2022; 9():991293. PubMed ID: 36072876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation.
    Lee SR; Rhee TM; Kang DY; Choi EK; Oh S; Lip GYH
    Am J Cardiol; 2019 Sep; 124(6):879-885. PubMed ID: 31311662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.
    Ten Berg JM; de Veer A; Oldgren J; Steg PG; Zateyshchikov DA; Jansky P; Seung KB; Hohnloser SH; Lip GYH; Nordaby M; Kleine E; Bhatt DL; Cannon CP;
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2331-2341. PubMed ID: 31806214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
    Kopin D; Jones WS; Sherwood MW; Wojdyla DM; Wallentin L; Lewis BS; Verheugt FWA; Vinereanu D; Bahit MC; Halvorsen S; Huber K; Parkhomenko A; Granger CB; Lopes RD; Alexander JH
    Am Heart J; 2018 Mar; 197():133-141. PubMed ID: 29447773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
    Sherwood MW; Vora AN
    Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting.
    Lacoste JL; Hansen CL
    Am J Health Syst Pharm; 2019 Sep; 76(18):1395-1402. PubMed ID: 31505555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D;
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
    Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
    BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen.
    Kawakami S; Yasuda S; Ogawa H
    J Cardiol; 2020 Jul; 76(1):35-43. PubMed ID: 32389534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis.
    Chen CF; Chen B; Zhu J; Xu YZ
    Herz; 2015 Dec; 40(8):1070-83. PubMed ID: 26135462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies.
    Bainey KR; Morais J; Zeymer U; Welsh RC
    Atherosclerosis; 2019 Oct; 289():118-125. PubMed ID: 31494384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Goto K; Nakai K; Shizuta S; Morimoto T; Shiomi H; Natsuaki M; Yahata M; Ota C; Ono K; Makiyama T; Nakagawa Y; Furukawa Y; Kadota K; Takatsu Y; Tamura T; Takizawa A; Inada T; Doi O; Nohara R; Matsuda M; Takeda T; Kato M; Shirotani M; Eizawa H; Ishii K; Lee JD; Takahashi M; Horie M; Takahashi M; Miki S; Aoyama T; Suwa S; Hamasaki S; Ogawa H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Am J Cardiol; 2014 Jul; 114(1):70-8. PubMed ID: 24925801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Antithrombotic Therapy in Atrial Fibrillation Patients with a History of Percutaneous Coronary Intervention.
    Horiguchi A; Fukaya H; Oikawa J; Shirakawa Y; Kobayashi S; Arakawa Y; Nishinarita R; Nakamura H; Ishizue N; Igarashi G; Satoh A; Kishihara J; Niwano S; Ako J
    Int Heart J; 2019 Nov; 60(6):1321-1327. PubMed ID: 31735777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double Antithrombotic versus Triple Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome.
    Dharma S
    Int J Angiol; 2020 Jun; 29(2):81-87. PubMed ID: 32476809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial.
    Sherwood MW; Cyr DD; Jones WS; Becker RC; Berkowitz SD; Washam JB; Breithardt G; Fox KA; Halperin JL; Hankey GJ; Singer DE; Piccini JP; Nessel CC; Mahaffey KW; Patel MR
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1694-702. PubMed ID: 27539689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
    Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D
    Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
    Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
    Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.